Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage.

Pacira BioSciences, Inc. (PCRX), a provider of non-opioid pain management and regenerative health solutions, Thursday announced that ...